Semaglutide, known under brand names like Ozempic and Wegovy, is a powerful GLP-1 receptor agonist originally developed to manage type 2 diabetes, but now widely used for chronic weight management. It works by mimicking the GLP-1 hormone in your body, which regulates blood sugar, slows digestion, and reduces appetite. This leads to fewer cravings, smaller portions, and effective long-term weight loss without the need for extreme diets.

​

Ozempic is FDA-approved for diabetes but is often prescribed off-label for weight loss, while Wegovy is specifically approved for weight management in people with obesity or weight-related conditions such as high blood pressure, high cholesterol, or type 2 diabetes. Many users report impressive transformations, with improved metabolic health, reduced inflammation, and sustained fat loss over time.